Xcout IntelLENSAR, Inc. competitors & alternatives
The 12 closest competitors and alternatives to LENSAR, Inc. among medical devices companies — ranked by similarity to what LENSAR, Inc. actually does, not by market-cap band.
Subscribe to see LENSAR, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About LENSAR, Inc.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
LENSAR, Inc. at a glance
LENSAR, Inc. is a medical devices company headquartered in Orlando, United States, founded in 2004. It is publicly listed (LNSR) with a market capitalisation of $80M. Xcout tracks 13 named people at LENSAR, Inc., including Nicholas T. Curtis (President, Chief Executive Officer & Director).
LENSAR, Inc. leadership
- Nicholas T. CurtisPresident, Chief Executive Officer & Director
- Alan ConnaughtonChief Operating Officer
- Michael A. RossiInterim CFO & Principal Financial Officer and Secretary
- Kendra W. WongPrincipal Accounting Officer
- Aimee S WeisnerDirector
- Elizabeth G. O'FarrellDirector
7 more named people on record for LENSAR, Inc., with roles, board committees and tenure — see the full roster →
LENSAR, Inc. funding rounds before its IPO
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $87M | — |
Financing after the IPO — public offerings and SEC Form D private placements — is not listed as a funding round.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 LENSAR, Inc. competitors
Ranked by semantic similarity — how close each company is to LENSAR, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Medical - Devices
As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.
Similar medical devices company
Horizon Surgical Systems is a medical device company developing assistive surgical robotics. Its Polaris platform is designed to support surgeons, enhance precision, and expand access to quality eye care.
Similar medical devices company
STAAR Surgical Company, along with its subsidiaries, specializes in ophthalmological solutions, focusing on the design, development, manufacturing, and commercialization of implantable lenses for vision correction, complete with the sophisticated delivery systems necessary for their implantation. A core offering is the Visian implantable Collamer lens (ICL) product line, designed to correct various visual impairments including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia (age-related loss of near vision). Specifically, their Hyperopic ICL addresses farsightedness. Furthermore, STAAR Surgical provides preloaded silicone intraocular lenses and associated injector systems, crucial for cataract surgery. The company also sells various injector components and ancillary medical instruments and devices. Its market outreach extends to a diverse array of healthcare providers, such as ophthalmic surgeons, specialized vision and surgical centers, hospitals, governmental healthcare facilities, and distributors. These products are predominantly utilized by ophthalmologists. Sales are conducted directly via its own sales force in key countries like the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore. In other significant markets, including China, Korea, India, France, the Benelux region, Italy, and other international territories, the company employs a hybrid sales model, leveraging both its direct representatives and independent distributors. Founded in 1982, STAAR Surgical Company is headquartered in Lake Forest, California.
Similar medical devices company
Johnson & Johnson Surgical Vision is a division of Johnson & Johnson Vision, which is a subsidiary of the global healthcare company Johnson & Johnson. The company focuses on surgical vision products and maintains its headquarters in Jacksonville, Florida.
Similar medical devices company
Lightfield Medical develops Lightfield Captura, an autonomous slit-lamp imaging system designed for ophthalmology and optometry practices. The cloud-connected device enables delegated staff to capture, document, and store consistent anterior eye images for review by qualified physicians.
Similar medical devices company
Omega Ophthalmics LLC develops the Gemini Capsule, an investigational medical implant designed to keep the capsular bag open and provide a stable position for intraocular lenses following cataract removal. The company serves the ophthalmic medical and business sectors by offering solutions to address post-operative capsular contraction.
Similar medical devices company
Asensus Surgical, Inc. is a MedTech company headquartered in Morrisville, North Carolina, United States. The company provides highly advanced robotic surgical technology designed to empower surgeons with unparalleled real-time insights for superior patient outcomes.
Therapeutic Devices
Adaptilens, Inc. is an ophthalmic medical device company headquartered near Boston, Massachusetts, focused on developing advanced accommodating intraocular lenses (IOLs). Founded by ophthalmic device inventors, the company aims to restore natural range of vision for cataract patients through innovative lens technologies. It conducts clinical evaluations and secures venture backing to advance its medical device pipeline.
Similar medical devices company
Elios Vision, Inc. provides next-generation glaucoma treatment solutions designed to address glaucoma during routine cataract surgery. The available evidence does not explicitly state its headquarters country.
Similar medical devices company
EyeYon Medical Ltd. is an ophthalmic device company that develops products and treatments for corneal diseases and vision-threatening conditions, including its flagship product EndoArt, an artificial endothelial layer for corneal edema. The company specializes in corneal health solutions, synthetic corneal implants, and advanced drug-delivery systems.
Therapeutic Devices
LumiThera, Inc. is an ophthalmic medical device company that harnesses the power of light to offer a comprehensive approach for detecting and treating eye conditions.
Similar medical devices company
Lentechs is a clinical-stage ophthalmic medical device company that develops patented soft, suspended contact lenses designed for individuals with presbyopia. Its technology is engineered to be suspended behind the upper eyelid to allow free eye movement behind a rotationally-stable lens, providing vision correction at multiple distances.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of LENSAR, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for LENSAR, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →